| abstract |
The invention relates to methods of modulating immune cells in a patient by altering microbiota of the npatient. The invention also relates to methods of modulating treatments or therapies in a subject norganism by altering microbiota of the subject. The invention also relates to cell populations, systems, narrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective ntargeting of a particular species in a human gut microbiota using guided nucleic acid modification is ncarried out to effect the alteration. n[FIGURE 12] n17627383_1 (GHMatters) P110251.AU.3n12/17 nIru n-o ac n0. n-nto nto n0 nU: nLIn |